# PROCHLORPERAZINE EDISYLATE
> **ANDA213626** · Abbreviated New Drug Application (Generic) · Sponsor: VIWIT PHARM · Approved 2021-09-28
## Drug
- **FDA Application Number:** ANDA213626
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PROCHLORPERAZINE EDISYLATE
- **Generic name:** PROCHLORPERAZINE EDISYLATE
- **Active ingredients:** PROCHLORPERAZINE EDISYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** VIWIT PHARM
- **Manufacturer:** Cosette Pharmaceuticals, Inc.
- **First approval:** 2021-09-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213626)
---
*MORVS · CC0 1.0*